» » »

CRISPR Biology and Biotechnology: the Future of Genome Editing

Jennifer Doudna

Programmable proteins that detect and cut specific DNA sequences were uncovered by research to understand how bacteria fight viral infections. In collaboration with Emmanuelle Charpentier’s laboratory, we determined how the enzyme Cas9, which is part of CRISPR-Cas adaptive bacterial immunity, can be harnessed as a powerful technology to alter genomic sequences in cells. This created a simple, precise and widely adaptable technology for genome editing - changing or regulating the genetic material - in any cell or organism. Current research is exploring the diversity of CRISPR-Cas systems in microbes and developing genome editing for biomedical and agricultural applications. I will also discuss the ethical and societal implications of genome editing.

Speaker: Jennifer Doudna, UC Berkeley

Monday, 02/04/19


Website: Click to Visit



Save this Event:

Google Calendar
Yahoo! Calendar
Windows Live Calendar

SLAC Colloquium Series

Panofsky Auditorium
2575 Sand Hill Road
Menlo Park, CA 94025

Phone: 650-926-8537
Website: Click to Visit